Related Experiment Videos
Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis
Ferah Genel1, Serpil Erermis, Guzide Aksu
1Department of Pediatrics, Ege University, The Medical School, Izmir, Turkey. ferahgen@yahoo.com
Insights
Quinacrine, an antiparasitic drug, can cause serious psychiatric side effects. This case highlights severe neuropsychiatric reactions in a boy with immunodeficiency treated for giardiasis.
Area of Science:
- Pharmacology
- Infectious Diseases
- Psychiatry
Background:
- Quinacrine is an antiparasitic agent used for treating infections like giardiasis.
- Psychiatric complications associated with quinacrine therapy are rare but significant.
- Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder.
Observation:
- A 12-year-old boy with CVID received quinacrine for chronic, resistant giardiasis.
- The patient experienced severe psychiatric reactions during the course of treatment.
- The specific nature of these reactions spanned a broad clinical spectrum.
Findings:
- The case demonstrates a link between quinacrine administration and severe neuropsychiatric disturbances.
- The patient's underlying condition (CVID) may influence susceptibility or presentation of side effects.
- The severity of the psychiatric reactions underscores the potential risks of quinacrine therapy.
Implications:
- Clinicians should be aware of the potential for serious psychiatric adverse events with quinacrine.
- Careful patient monitoring is crucial during quinacrine treatment, especially in immunocompromised individuals.
- Further research may be needed to understand risk factors and management strategies for quinacrine-induced neuropsychiatric disorders.
Abstract:
Psychiatric disorders due to quinacrine for antiparasitic therapy represent an infrequent, but serious, complication. The remarkable course of a 12-year-old boy with common variable immunodeficiency who developed severe psychiatric reactions following quinacrine therapy for his resistant chronic giardiasis is presented. The broad clinical spectrum of quinacrine-associated neuropsychiatric disturbances has been emphasized for the clinicians.